XML 24 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Public Offering
ATM Program
Common Stock
Common Stock
Public Offering
Common Stock
ATM Program
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Additional Paid-in Capital
ATM Program
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance beginning of period (in shares) at Dec. 31, 2021       67,344,374              
Balance beginning of period at Dec. 31, 2021 $ 1,571,552     $ 67     $ 5,452,550     $ (3,876,743) $ (4,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 52,233                 52,233  
Unrealized gain on derivatives 32,052                   32,052
Reclassification from interest expense, net 405                   405
Reclassification from equity in earnings of unconsolidated entities 604                   604
Distributions declared (55,337)                 (55,337)  
Stock-based compensation, net (in shares)       128,179              
Stock-based compensation, net 4,418           4,418        
Balance end of period (in shares) at Dec. 31, 2022       67,472,553              
Balance end of period at Dec. 31, 2022 1,603,909     $ 67     5,456,968     (3,879,847) 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 5,269                 5,269  
Unrealized gain on derivatives 6,228                   6,228
Reclassification from interest expense, net (14,875)                   (14,875)
Distributions declared (58,248)                 (58,248)  
Stock-based compensation, net (in shares)       127,238              
Stock-based compensation, net $ 7,428     $ 1     7,427        
Issuance of common stock under offering, net (in shares)           208,040          
Issuance of common stock under offering, net     $ 4,333           $ 4,333    
Balance end of period (in shares) at Dec. 31, 2023 67,807,831     67,807,831              
Balance end of period at Dec. 31, 2023 $ 1,554,044     $ 68     5,468,728     (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 13,658                 13,658  
Unrealized gain on derivatives 9,019                   9,019
Reclassification from interest expense, net (12,667)                   (12,667)
Distributions declared (65,697)                 (65,697)  
Stock-based compensation, net (in shares)       188,881              
Stock-based compensation, net $ 8,185           8,185        
Issuance of common stock under offering, net (in shares)         9,200,000 254,082          
Issuance of common stock under offering, net   $ 245,843 $ 7,620   $ 9     $ 245,834 $ 7,620    
Balance end of period (in shares) at Dec. 31, 2024 77,450,794     77,450,794              
Balance end of period at Dec. 31, 2024 $ 1,760,005     $ 77     $ 5,730,367     $ (3,984,865) $ 14,426